Filing Details
- Accession Number:
- 0000899243-21-005020
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-05 16:20:09
- Reporting Period:
- 2021-02-03
- Accepted Time:
- 2021-02-05 16:20:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1596946 | Quotient Ltd | QTNT | In Vitro & In Vivo Diagnostic Substances (2835) | 264719797 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1604629 | Edward Farrell | C/O Quotient Limited 28 Esplanade St Helier Y9 JE2 3QA | Chief Operating Officer (+) | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2021-02-03 | 96,000 | $0.00 | 125,757 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2021-02-03 | 96,000 | $5.07 | 29,757 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Options to acquire ordinary shares | Disposition | 2021-02-03 | 96,000 | $0.00 | 96,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-04-10 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Employee Stock Option (right to buy) | $11.92 | 2026-05-31 | 30,000 | 30,000 | Direct | |
| Ordinary Shares | Employee Stock Option (right to buy) | $15.17 | 2025-05-19 | 30,000 | 30,000 | Direct | |
| Ordinary Shares | Employee Stock Option (right to buy) | $8.00 | 2024-04-29 | 79,000 | 79,000 | Direct | |
| Ordinary Shares | Employee Stock Option (right to buy) | $7.58 | 2027-05-23 | 40,000 | 40,000 | Direct | |
| Ordinary Shares | Restricted Stock Units | $0.00 | 12,257 | 12,257 | Direct | ||
| Ordinary Shares | Restricted Stock Units | $0.00 | 30,000 | 30,000 | Direct | ||
| Ordinary Shares | Restricted Stock Units | $0.00 | 1,488 | 1,488 | Direct | ||
| Ordinary Shares | Restricted Stock Units | $0.00 | 55,000 | 55,000 | Direct | ||
| Ordinary Shares | Ordinary Share Option (Right to Buy) | $4.72 | 2030-10-31 | 20,000 | 20,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2026-05-31 | 30,000 | 30,000 | Direct |
| 2025-05-19 | 30,000 | 30,000 | Direct |
| 2024-04-29 | 79,000 | 79,000 | Direct |
| 2027-05-23 | 40,000 | 40,000 | Direct |
| 12,257 | 12,257 | Direct | |
| 30,000 | 30,000 | Direct | |
| 1,488 | 1,488 | Direct | |
| 55,000 | 55,000 | Direct | |
| 2030-10-31 | 20,000 | 20,000 | Direct |
Footnotes
- Restricted Stock Units convert into ordinary shares on a one-for-one basis.
- All 30,000 options have vested and remain exercisable.
- All 30,000 options have vested and remain exercisable.
- The exercise price was paid in pounds sterling, at GBP0.003 per share.
- All 96,000 options have vested and have been exercised.
- All 79,000 options have vested and remain exercisable.
- All 40,000 options have vested and remain exercisable.
- On May 24, 2018, the Reporting Person was granted 36,773 Restricted Stock Units, of which 24,516 have vested and have been exercised. The remaining 12,257 Restricted Stock Units will vest on May 24, 2021.
- On May 24, 2019, the Reporting Person was granted 45,000 Restricted Stock Units, of which 15,000 have vested and have been exercised. The remaining 30,000 Restricted Stock Units will vest in two equal installments on May 24, 2021 and May 24, 2022.
- On January 7, 2020, the Reporting Person was granted 2,232 Restricted Stock Units, of which 744 have vested and have been exercised. The remaining 1,488 Restricted Stock Units will vest in two equal installments on January 7, 2022 and January 7, 2023.
- On May 24, 2020, the Reporting Person was granted 55,000 Restricted Stock Units, vesting in three equal annual installments beginning May 24, 2021.
- The option vests and becomes exercisable in three equal annual installments beginning October 31, 2021.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.19, inclusive. The Reporting Person undertakes to provide to Quotient Limited and any security holder of Quotient Limited, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (13) to this Form 4.
Billionaire Hedge Funds
